Cardax, Inc.

CDXI · OTC
Analyze with AI
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenue$539$711$1,511$610
% Growth-24.2%-52.9%147.6%
Cost of Goods Sold$196$345$700$275
Gross Profit$343$366$811$336
% Margin63.6%51.4%53.7%55%
R&D Expenses$137$316$269$461
G&A Expenses$3,234$4,087$4,534$1,312
SG&A Expenses$3,234$4,087$4,534$1,847
Sales & Mktg Exp.$0$0$0$535
Other Operating Expenses$35$40$31$29
Operating Expenses$3,405$4,443$4,834$2,338
Operating Income-$3,063-$4,077-$4,022-$2,002
% Margin-568.3%-573.5%-266.2%-328.1%
Other Income/Exp. Net-$1,993-$1,016-$2$17
Pre-Tax Income-$5,056-$5,093-$4,024-$1,985
Tax Expense$0$0$5$0
Net Income-$5,056-$5,093-$4,024-$1,985
% Margin-938%-716.4%-266.4%-325.3%
EPS-6.79-8.4-6.32-3.97
% Growth19.2%-32.9%-59.2%
EPS Diluted-6.79-8.4-6.32-3.97
Weighted Avg Shares Out745680637500
Weighted Avg Shares Out Dil745680637500
Supplemental Information
Interest Income$0$0$2$3
Interest Expense$2,385$623$4$4
Depreciation & Amortization$35$40$31$29
EBITDA-$2,636-$4,430-$3,994-$1,973
% Margin-489.2%-623.1%-264.3%-323.3%
Cardax, Inc. (CDXI) Financial Statements & Key Stats | AlphaPilot